UnitedHealthCare UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies Several analysts said that the decision by UHC, the largest private payor in the US, will especially benefit Natera. Myriad Genetics GeneSight PGx Test Garners UnitedHealthcare Coverage The firm said that UHC will cover the test for patients with major depressive disorder or anxiety who have failed to respond to one or more treatments. CMS Draft Coverage Policy on NGS Cancer Tests Raises Questions About Where Commercial Payors Stand Premium Executives at two commercial payors said they'd follow CMS' lead when it comes to patients covered under Medicare but beyond that their support for the agency's policy is less clear. Insurers Turn to Automated Prior Authorization Programs to Rein in Genetic Testing Use Premium Payors say online, automated systems will bring standardization and efficiency to prior authorizations, but doctors and labs are uncertain about the impact on patient care. Interpace Q2 Revenues Grow 8 Percent During the quarter, the firm secured payor coverage for its tests with UnitedHealthcare, Premera Blue Cross, and Aetna. Jun 30, 2017 UnitedHealthcare Implementing Prior Authorization Program for Genetic, Molecular Tests Jun 21, 2017 Myriad Genetics Signs Pricing Agreement With United Healthcare for Several Tests May 31, 2017 United Healthcare Includes Exact Sciences' Cologuard in Coverage Document Apr 18, 2017 Interpace's ThyraMir Receives Coverage From UnitedHealthcare May 3, 2016 Roche's Ariosa Harmony Noninvasive Prenatal Test Gets Coverage From Large Private Insurers in US Jan 21, 2016 UnitedHealthcare Agrees to Cover Paradigm Cancer Diagnostic Dec 21, 2015 UnitedHealthcare Covers Foundation Medicine Test for Metastatic Lung Cancer Oct 14, 2015 Good Start Genetics, UnitedHealthcare Pen Agreement for Genetic Screening Services Sep 17, 2015 Sequenom Inks National Coverage Agreement with UnitedHealthcare for Prenatal Dx May 12, 2015 UnitedHealthcare Issues Positive Coverage Decision for VeriStrat May 1, 2015 PMC Paper Asks Policymakers to Consider Impact of Alternative Payment Models on Personalized Rx Premium Nov 7, 2014 Early Interaction with Payors Key to Indi's Success in Winning Coverage for Xpresys Lung Premium Aug 7, 2014 UnitedHealthcare to Reimburse for NanoString's Prosigna Breast Cancer Test May 7, 2014 Myriad’s UHC Contract for myRisk Offers Patients Tested on Older Dx Chance to Get NGS Premium May 6, 2014 Myriad Signs Contract with UnitedHealthcare for MyRisk Hereditary Cancer Risk Panel Mar 8, 2013 UnitedHealthcare Starting Coverage of Veractye's Thyroid Cancer MDx Mar 5, 2013 UnitedHealthcare Joins List of National Payors Supporting Non-invasive Prenatal Diagnostic Testing Nov 7, 2012 UnitedHealthcare Sees Need for National Registry to Track Use, Set Coverage of Molecular Tests Premium Feb 9, 2011 Aurora to Use Oracle's Informatics Muscle to Run More Efficient Clinical Trials; PGx in Long View Premium Dec 8, 2010 Payors Weigh in on Interface of Personalized Medicine and Comparative Effectiveness Research Premium Load More Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.